WELL Health Technologies Completes Acquisition of Jack Nathan Health's Canadian Clinical Assets Begins to Operate Clinics at ...
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, unveiled new pharmacokinetic ("PK") data from its Phase 2a Eosinophilic Esophagitis ("EoE") program.
The BC Centre for Innovation and Clean Energy (CICE) is investing $590,000 in Burnaby-based Ekona Power as part of a recent $4.2 million investment in seven BC climate tech companies, selected from 79 ...
Scientific results demonstrate the company's achievements in creating fusion through MTF, providing foundation for its LM26 fusion demonstration, which will begin compressing large-scale plasmas in ...